Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Claritev (CTEV) EBITDA (2019 - 2026)

Claritev has reported EBITDA over the past 7 years, most recently at -$79.6 million for Q4 2025.

  • For Q4 2025, EBITDA rose 39.03% year-over-year to -$79.6 million; the TTM value through Dec 2025 reached -$283.4 million, up 82.71%, while the annual FY2025 figure was -$283.4 million, 82.71% up from the prior year.
  • EBITDA for Q4 2025 was -$79.6 million at Claritev, down from -$69.0 million in the prior quarter.
  • Over five years, EBITDA peaked at $78.2 million in Q3 2021 and troughed at -$650.1 million in Q4 2022.
  • A 5-year average of -$124.8 million and a median of -$45.2 million in 2021 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: surged 1868.58% in 2021 and later tumbled 254237.32% in 2024.
  • Year by year, EBITDA stood at $24.9 million in 2021, then tumbled by 2707.02% to -$650.1 million in 2022, then soared by 93.3% to -$43.6 million in 2023, then tumbled by 199.8% to -$130.6 million in 2024, then surged by 39.03% to -$79.6 million in 2025.
  • Business Quant data shows EBITDA for CTEV at -$79.6 million in Q4 2025, -$69.0 million in Q3 2025, and -$61.9 million in Q2 2025.